Cardiac MRI for Patients Enrolled in INFUSE-AMI
|ClinicalTrials.gov Identifier: NCT01059214|
Recruitment Status : Completed
First Posted : January 29, 2010
Last Update Posted : April 5, 2018
- INFUSE AMI is an ongoing clinical trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with specific kinds of heart attacks caused by blood clots.
- To evaluate the effect of the heart attack on the heart tissue and function, participants in the INFUSE-AMI study will have magnetic resonance imaging (MRI) scans of the heart at specific times after their heart attack.
- To perform cardiac MRI scans on patients who are participating in the INFUSE-AMI study.
- Individuals at least 18 years of age who are enrolled in the INFUSE-AMI study.
- Participants will have an MRI scan of the heart about 5 days and between 23 and 44 days after their heart attack. The MRI scan at day 5 is optional.
- Participants will provide a blood sample prior to the MRI scan.
- During the scan, participants will be given a contrast drug to show the blood flow to and within the heart. An electrocardiogram will be used to monitor the heart during the procedure.
- No other treatment will be provided in this protocol.
|Condition or disease|
|Acute Myocardial Infarction Coronary Artery Disease Myocardial Fibrosis Gadolinium Myocardial Edema|
|Study Type :||Observational|
|Actual Enrollment :||455 participants|
|Official Title:||Cardiac MRI for Patients Enrolled in INFUSE-AMI|
|Study Start Date :||December 10, 2009|
|Study Completion Date :||October 11, 2012|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01059214
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Andrew E Arai, M.D.||National Heart, Lung, and Blood Institute (NHLBI)|